E/M Coding Alert - 2003 Issue 8
Antitrust: DOJ, FTC REEXAMINE HEALTH CARE ANTITRUST
Subscribe or sign in to view the full article.
Article Overview
This article covers a forthcoming series of federal hearings led by the Department of Justice and the Federal Trade Commission on competition and health care policy. It is relevant to health care organizations, compliance teams, and policy watchers who want to understand the broader regulatory and market issues being examined, including consolidation, patient access, quality measurement, and the application of antitrust laws to health care providers.
Why This Topic Matters
The hearings may influence how federal agencies evaluate competition and consolidation in health care markets, which can affect provider organization strategy, compliance planning, and access-to-care considerations.
What You Will Learn
- The scope and purpose of the upcoming federal hearings on health care competition
- The main policy areas under review, including consolidation, access to care, and quality measurement
- Which federal agencies are involved and the general timing of the hearing series
- How the hearings relate to antitrust policy in the health care sector
Who Should Read This
- Health care executives
- Compliance professionals
- Health care attorneys
- Policy analysts
- Provider organizations
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com